COMMUNIQUÉS West-GlobeNewswire

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

04/03/2025 - 22:05

IRVINE, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., Chief Scientific Officer and President, will participate in a fireside [...]

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/03/2025 - 22:05

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly- [...]

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

04/03/2025 - 22:05

-- Record quarterly revenue of $21.5 million in Q4 2024 -- -- Full-year 2025 revenue guidance of $92 to $96 million -- -- Completed an underwritten public offering of $74.8 million, using $49.5 million of the net [...]

Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL’36), a Novel Once-Daily Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease

04/03/2025 - 22:05

Statistically significant improvement in primary endpoint (UDysRS total scale) at Week 4 and positive benefit in the key secondary endpoint (UDysRS objective subscale), beginning at Day 7 Favorable tolerability profile [...]

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

04/03/2025 - 22:05

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]

BeautyHealth to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

04/03/2025 - 22:05

LONG BEACH, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2024 financial results [...]

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

04/03/2025 - 22:05

Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“ [...]

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

04/03/2025 - 22:01

U.S. FDA approved Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the treatment of inflammatory lesions of rosacea in adults in November 2024 [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04/03/2025 - 22:01

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

04/03/2025 - 22:01

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025

04/03/2025 - 21:53

Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6 [...]

BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates

04/03/2025 - 21:28

March 4, 2025 Announcement no. 04 BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates COPENHAGEN, DENMARK, March 4 [...]

NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

04/03/2025 - 21:13

UNION, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- NanoNewron, LLC (“NanoNewron” or the “Company”), a pioneering biotechnology company developing innovative, humanized biologics that cross the blood-brain barrier (BBB) to [...]

Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

04/03/2025 - 20:06

HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics , Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for [...]

Eurobio Scientific : résiliation du contrat de liquidité

04/03/2025 - 20:03

RÉSILIATION DU CONTRAT DE LIQUIDITÉ Paris, le 4 mars 2025 –19h50 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences de la vie, annonce [...]

NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented

04/03/2025 - 19:00

Trading commencing on the OTC Markets on March 5, 2025. Trading expected to continue under ticker symbol “NKGN” for common stock and “NKGNW” for warrants. NKGen Biotech, Inc. (“NKGen” or the “Company”) has regained [...]

USAHS Doctor of Physical Therapy Program in Austin Offers Free Basic Screening Services to the Austin Community

04/03/2025 - 18:58

USAHS furthers its commitment to the Austin community by offering accessible physical therapy screening services led by students and faculty. AUSTIN, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- The University of St. [...]

Iridia Makes History: First Cryptocurrency and Molecular Off-World Data Archive Successfully Lands on the Moon

04/03/2025 - 18:00

Groundbreaking Molecular Data Technology Establishes Humanity's First Permanent Lunar Data Repository Using Molecular Storage SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Iridia, the pioneering molecular technology [...]

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

04/03/2025 - 17:58

Company Announcement COPENHAGEN, Denmark; March 4, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]